These links are provided for your convenience. However, they lead to external Web sites not created, managed, or maintained by Baxter. Baxter is not responsible for, and does not necessarily endorse, the opinions or therapeutics represented on these external pages.
www.hrsa.gov
Health Resources and Services Administration, Department of Health
www.ssa.gov
Social Security
www.dhhs.gov
Dep. Of Health & Human Services
www.cms.hhs.gov
Medicare and Medicaid services
www.kff.org
Independent source of facts about health care from the Kaiser Family Foundation
www.insurekidsnow.gov
Links to low-cost insurance programs
www.ahip.org
America's Health Insurance Plans
www.healthinsuranceinfo.net
Consumer guides to getting and keeping health insurance
Free insurance counseling is also available by state.
See this site for a directory of "State Insurance Counseling."
Alaska Comprehensive Health Association:
www.achia.com
California Managed Risk Medical Insurance Board:
www.mrmib.ca.gov
Colorado Uninsurable Health Insurance Plan:
www.covercolorado.org
Illinois Comprehensive Health Insurance Plan:
www.chip.state.il.us
Indiana Comprehensive Health Insurance Association:
www.onlinehealthplan.com/oasys
Kentucky Access:
www.onlinehealthplan.com/oasys
Louisiana Health Insurance Association:
www.lahealthplan.org
Mississippi Comprehensive Health Insurance Pool:
www.doi.state.ms.us/htm_files/mchirpa.html
Missouri Health Insurance Pool:
www.mhip.org
Nebraska Comprehensive Health Insurance Plan:
www.state.ne.us/home/NDOI/brochure/b_chip.htm
Comprehensive Health Association of North Dakota:
www.chand.org
Oregon Medical Insurance Pool:
www.omip.state.or.us
TennCare:
www.state.tn.us/tenncare
Wisconsin Health Insurance Risk Sharing Plan:
www.dhfs.state.wi.us/hirsp/index.htm
Indications:
ADVATE [Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method] is indicated in hemophilia A (classical hemophilia) for the prevention and control of bleeding episodes and for perioperative management of patients with hemophilia A.
ADVATE is not indicated for the treatment of von Willebrand’s disease.
Important Safety Information:
Let your doctor know if you have had any previous allergic reactions to other factor VIII products or mouse or hamster proteins.
The most common related adverse reactions observed during the ADVATE clinical studies include: strange taste in mouth, headache, dizziness, and redness in the face.
There is a possibility that you can have an allergic reaction to ADVATE. Symptoms of an allergic reaction may include rash, hives, itching, tightness in throat or chest, difficulty breathing, feeling dizzy or light-headed, or a weak pulse. If you experience any of these symptoms, stop the infusion immediately and promptly contact your doctor.
Contact your doctor if you are not able to prevent or control bleeding episodes with your regular doses of factor VIII therapy.
